Arcutis Biotherapeutics, Inc.
ARQT
Revenue
30.86M
▼-18.71M▼-37.75%
3 Months ChangeAssets
444.76M
▼-33.78M▼-7.06%
3 Months ChangeLiabilities
258.33M
▲4.73M▲1.87%
3 Months ChangeFree Cash Flow
-31.60M
▲48.82M▲60.71%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 10-Q
ID: 0001787306-24-000124
2024-08-14
Form 8-K
ID: 0001787306-24-000122
2024-06-18
Form 8-K
ID: 0001787306-24-000090
2024-05-14
Form 10-Q
ID: 0001787306-24-000079
2024-05-14
Form 8-K
ID: 0001787306-24-000078
2024-04-10
Form 8-K
ID: 0001787306-24-000046
2024-03-04
Form 8-K
ID: 0001628280-24-008496
2024-02-28
Form 8-K
ID: 0001628280-24-007586
2024-02-27
Form 8-K
ID: 0001787306-24-000029
2024-02-15
Form 8-K
ID: 0001628280-24-005061